Verrica Pharmaceuticals Inc. IPO Research Information

Verrica Pharmaceuticals Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Verrica Pharmaceuticals Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Verrica Pharmaceuticals Inc.	VRCA - NASDAQ	$14.00-$16.00	$15.00	$20.00	5 million	6/15/2018
Underwriter(s): BofA Merrill Lynch, Jefferies, Cowen
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2018-05-22 Terms Added 2018-06-05 Final Prospectus 2018-06-15

Verrica Pharmaceuticals Inc. Quote & Chart - Click for current quote - VRCA

About Verrica Pharmaceuticals Inc. (adapted from Verrica Pharmaceuticals Inc. prospectus):
They are a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "VRCA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.